Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-21-002379

Director sold 10,000 shares at an average $57.34 ($573,369)

  • Director acquired 10,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

DOBMEIER ERIC · Director

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2021-01-04 Exercise or conversion : show line 1 in the form +10,000 $6.32 $63,200 10,000 D
2021-01-04 Sale : show line 2 in the form −3,283 $56.10 $184,176 6,717 D
2021-01-04 Sale : show line 3 in the form −5,725 $57.76 $330,676 992 D
2021-01-04 Sale : show line 4 in the form −592 $58.67 $34,733 400 D
2021-01-04 Sale : show line 5 in the form −400 $59.46 $23,784 0 D
Open-market sales · 10,000 sh · avg $57.34 · $573,369

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-01-04 Exercise or conversion : show line 6 in the form Stock Option (Right to Buy) −10,000 35,000 D
Loading xslF345X03/doc4.xml…